Shinshoji Co., Ltd. (Head office: Shinjuku, Tokyo) has signed an exclusive agreement to introduce EXOMERE, a premium anti-aging skincare line born in Korea. By pairing the regenerative power of exosomes with insights from telomere research, EXOMERE shortens the turnover cycle from the conventional 28 days to just 3–5 days. The collection will be rolled out to luxury salons and retail partners nationwide with full support for compliance, training, and storytelling.
Brand story — what is EXOMERE?
EXOMERE awakens the skin with micro-exosomes while applying telomere science to maintain youthful longevity. The dual approach delivers immediate tone-up effects as well as long-term firmness, barrier reinforcement, and resilience.
Core concept
- 28 days → 3–5 days turnover: Optimized rhythm reveals clarity and even tone in record time.
- Deep regenerative signals: Micro exosomes target cells directly to boost bounce and density.
- Longevity approach: Telomere-inspired formulas suppress cellular aging and sustain youthful function.
Our technology
EXOMERE HALLA™
Particles 1/1,200th the size of a hair strand deliver active ingredients precisely, maximizing absorption while powerful antioxidants suppress melanin production to prevent dark spots.
SPICUS™
Natural spicules derived from sea sponge create micro-channels that boost penetration and trigger a gentle resurfacing cycle without damaging the skin.
Founder’s vision
Founder Im Sang-suk has spent more than 28 years at the forefront of K-beauty. Guided by the belief that “cosmetics should protect and rejuvenate the skin,” she developed proprietary anti-aging technology and secured multiple international patents. EXOMERE embodies her research and passion, gaining global recognition among professional aestheticians.
What’s next
A Japan-exclusive professional line and home-care kit will debut from spring 2025. Salon onboarding programs, staff training, and promotional creative assets will be delivered as a bundle to maximize client experience. Updates will be shared through our newsletter and news page.
For inquiries about EXOMERE partnerships or distribution, please reach out via the contact form.